US Patent 11510888 Alleviating oxidative stress disorders with PUFA derivatives
Patent 11510888 was granted and assigned to Retrotope Inc. on November, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Mikhail S. Shchepinov0
Edits on 26 Apr, 2023
Golden AI
Infobox
Edits on 1 Apr, 2023
Golden AI
Infobox
Golden AI
Infobox
Patent Citations
Edits on 30 Nov, 2022
Golden AI
Edits made to:
Infobox (+12 properties)
Article (+422 characters)
US Patent 11510888 Alleviating oxidative stress disorders with PUFA derivatives
Article
Some aspects of the invention provide for essential fatty acids which are substituted in specific positions to slow down oxidative damage by Reactive Oxygen Species (ROS), and to suppress the rate of consequent formation of reactive products, for the purpose of preventing or reducing the damage associated with oxidative stress associated diseases such as neurological diseases and age-related macular degeneration (AMD).
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115108880
Date of Patent
November 29, 2022
0Patent Application Number
166693870
Date Filed
October 30, 2019
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11510888 Alleviating oxidative stress disorders with PUFA derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.